// COMPANY
AbbVie
SECTOR HEALTHCAREMENTIONS 3LAST SEEN JULY 19, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
3 SIGNALS
01
m_and_a·Data Driven VC·JULY 19, 2026
“Apogee Therapeutics, acquired by AbbVie at $10,900M, follows with no revenue multiple disclosed”
Source→02
m_and_a·PitchBook News·JUNE 23, 2026
“AbbVie agreed to buy biotech Apogee Therapeutics, which develops treatments for atopic dermatitis and other inflammatory diseases, in a $10.9 billion deal.”
Source→03
m_and_a·Axios Pro Rata
AI-extracted from podcast / newsletter / paper summaries. May contain errors.